Fluorinated derivatives of deferiprone

Details for Australian Patent Application No. 2008232262 (hide)

Owner Apotex Technologies Inc.

Inventors Wang, Yingsheng; Leung-Toung, Regis; Zhao, Yanquing; Tam, Tim Fat

Agent Fisher Adams Kelly

Pub. Number AU-A-2008232262

PCT Pub. Number WO2008/116301

Priority 60/907,290 28.03.07 US

Filing date 27 March 2008

Wipo publication date 2 October 2008

International Classifications

C07D 213/69 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 39/04 (2006.01) General protective or antinoxious agents

C07D 309/40 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116301 Priority application(s): WO2008/116301

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008232265-Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists

2008232260-Cancer disease modifying antibody 010207-01 produced by hybridoma cell line AR51A630.3.